The Surgical Instruments Manufacturers Association of Pakistan (SIMAP), in collaboration with the Trade Development Authority of Pakistan (TDAP), organised a seminar to discuss FDA Import Alert 76-01 and its impact on Pakistan’s surgical instruments industry.
SIMAP, TDAP hold seminar on FDA Import Alert 76-01
SIALKOT, Jun 11 (APP): The Surgical Instruments Manufacturers Association of Pakistan (SIMAP), in collaboration with the Trade Development Authority of Pakistan (TDAP), organised a seminar to discuss FDA Import Alert 76-01 and its impact on Pakistan’s surgical instruments industry.
The seminar aimed to raise awareness among manufacturers and exporters about the challenges currently being faced by Pakistani companies in the United States market. Experts provided detailed insights into the implications of the FDA alert.
Participants were guided on key compliance areas, including proper documentation, product traceability, and quality assurance measures. The session also highlighted the process and requirements for achieving FDA Green List status, which can help facilitate smoother access to the U.S. market.
Industry stakeholders actively participated in the event, gaining valuable information on regulatory compliance and export requirements.
The seminar concluded with an interactive question-and-answer session, where participants discussed practical challenges and sought expert guidance on meeting FDA standards.
